tiprankstipranks
Advertisement
Advertisement

GB:0JXZ Stock Latest News

Two new option listings and five option delistings on May 8th
The FlyTwo new option listings and five option delistings on May 8th
11d ago
CTRA
EXPI
Galapagos reports Q1 EPS EUR 0.22 vs. EUR (2.33) last year
PremiumThe Fly
Galapagos reports Q1 EPS EUR 0.22 vs. EUR (2.33) last year
13d ago
GLPG
Galapagos price target lowered to $28 from $33 at RBC Capital
PremiumThe Fly
Galapagos price target lowered to $28 from $33 at RBC Capital
1M ago
GLPG
Galapagos, Gilead enter pact to collaborate on T cell engager therapies
PremiumThe Fly
Galapagos, Gilead enter pact to collaborate on T cell engager therapies
2M ago
GILD
GLPG
Galapagos chairman Jerome Contamine to step down, Gino Santini to succeed
PremiumThe Fly
Galapagos chairman Jerome Contamine to step down, Gino Santini to succeed
2M ago
GLPG
Galapagos in partnership discussions with Gilead after Ouro deal
PremiumThe FlyGalapagos in partnership discussions with Gilead after Ouro deal
2M ago
GILD
GLPG
Galapagos CHRO Annelies Missotten to step down, Tania Philipp to succeed
Premium
The Fly
Galapagos CHRO Annelies Missotten to step down, Tania Philipp to succeed
2M ago
VOR
GLPG
0JXZ Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
0JXZ Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Bank of America Lifts Stake in Galapagos Above 5% Transparency Threshold
PremiumCompany Announcements
Bank of America Lifts Stake in Galapagos Above 5% Transparency Threshold
3M ago
Galapagos initiates the wind-down of cell therapy activities
PremiumThe Fly
Galapagos initiates the wind-down of cell therapy activities
4M ago
GLPG
Galapagos GALARISSO DM study meets primary endpoint, GALACELA SLE study misses
PremiumThe Fly
Galapagos GALARISSO DM study meets primary endpoint, GALACELA SLE study misses
5M ago
GLPG
Galapagos announce new ATALANTA-1 study data at ASH meeting
PremiumThe Fly
Galapagos announce new ATALANTA-1 study data at ASH meeting
5M ago
GLPG
Galapagos NV: Strategic Shift to Investment Entity Warrants Hold Rating Amid Opportunities and Risks
PremiumRatingsGalapagos NV: Strategic Shift to Investment Entity Warrants Hold Rating Amid Opportunities and Risks
6M ago
GLPG
Galapagos initiated with a Market Perform at Bernstein
Premium
The Fly
Galapagos initiated with a Market Perform at Bernstein
6M ago
GLPG
Galapagos price target raised to $32 from $28 at RBC Capital
Premium
The Fly
Galapagos price target raised to $32 from $28 at RBC Capital
6M ago
GILD
GLPG
Galapagos Unveils Promising Data for TYK2 Inhibitor GLPG3667
PremiumCompany Announcements
Galapagos Unveils Promising Data for TYK2 Inhibitor GLPG3667
7M ago
Galapagos price target raised to $28 from $27 at RBC Capital
PremiumThe Fly
Galapagos price target raised to $28 from $27 at RBC Capital
7M ago
GILD
GLPG
Leerink upgrades Galapagos on confidence after cell therapy exit
PremiumThe Fly
Leerink upgrades Galapagos on confidence after cell therapy exit
7M ago
GLPG
Galapagos upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
Galapagos upgraded to Outperform from Market Perform at Leerink
7M ago
GLPG
Galapagos intends to wind down cell therapy business
PremiumThe FlyGalapagos intends to wind down cell therapy business
7M ago
GILD
GLPG
Galapagos provides update on strategic alternatives for cell therapy business
Premium
The Fly
Galapagos provides update on strategic alternatives for cell therapy business
8M ago
GLPG
Galapagos granted RMAT designation to GLPG5101 by FDA
Premium
The Fly
Galapagos granted RMAT designation to GLPG5101 by FDA
10M ago
GLPG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >